Stay updated on Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2 and has removed older dates from March 2025, replacing them with newer dates in April 2025.
    Difference
    0.3%
    Check dated 2025-05-01T06:11:48.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed information about a clinical study evaluating daratumumab for multiple myeloma, while adding new drug names and identifiers related to the study.
    Difference
    17%
    Check dated 2025-04-16T20:26:56.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.3. The estimated last update posted has been removed.
    Difference
    0.1%
    Check dated 2025-04-09T13:28:40.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.2 to v2.14.3 and has added new dates for March and April 2025 while removing previous dates from February 2025.
    Difference
    0.3%
    Check dated 2025-04-02T00:10:24.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-24T23:00:16.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The webpage has updated its content to reflect new dates and locations, replacing previous entries with more recent information. Notably, the last update date has changed from May 2024 to February 2025.
    Difference
    0.8%
    Check dated 2025-02-17T19:15:24.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.